Skip to main content
. 2012 Sep 14;6:653–661. doi: 10.2147/PPA.S33968

Table 2.

Characteristics of patients treated with oral blood glucose-lowering drugs by treatment group

Descriptive characteristics Patients treated with oral blood glucose lowering drugs Monotherapy Fixed combination Dual therapy
No of patients with diabetes* 169,375 91,816 31,674 19,573
54.2% 18.7% 11.6%
Prevalence 4.2% 2.3% 0.8% 0.5%
Female 3.9% 2.2% 0.7% 0.4%
Male 4.5% 2.4% 0.8% 0.5%
Average age 68.9 68.3 71.9 67.5
% of females 49.1% 49.8% 49.4% 47.0%
Mean no of prescribed packs/year 72.5 66.6 71.2 86.8
For oral blood glucose lowering drugs 17.7 13.1 16.4 31.4
For insulin 1.0 1.0 1.0 1.0
For other drugs 54.8 53.6 54.7 55.5
DDD 1000 persons/day 175.6 85.2 32.2 26.1
For oral blood glucose lowering drugs 40.8 14.6 7.3 9.6
For insulin 3.9 2.2 0.7 0.5
For other drugs 134.8 70.6 24.9 16.4
Mean no of hospitalization/year (per 1000 patients) 328‰ 328‰ 314‰ 298‰
Mean no of specialist examinations/year 35.1 34.0 30.1 38.6

Notes:

*

The 169,375 patients include both the sum of patients in monotherapy, fixed combination and dual thearpy (∑ = 143,063), and patients in mixed therapy: (N = 26,312).

Abbreviation: DDD, defined daily dose.